isomethyleugenol has been researched along with End Stage Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, GB; M K, S; Manrai, M; Mishra, Y; Misra, P; Mukherjee, B; Negi, R; S V, A; Singh, A; Singh, MU; Singh, R | 1 |
| Baron, U; Bova, R; Füldner, A; Göldner, K; Kotsch, K; Melloh, GC; Olek, S; Pratschke, J; Stauch, D; Weiss, S; Yahyazadeh, A | 1 |
2 other study(ies) available for isomethyleugenol and End Stage Liver Disease
| Article | Year |
|---|---|
Association of promoter methylation status of NRF2 and PNPLA3 genes in alcoholic liver disease.
Topics: End Stage Liver Disease; Ethanol; Genetic Predisposition to Disease; Humans; Liver; Liver Diseases, Alcoholic; Methylation; NF-E2-Related Factor 2; Polymorphism, Single Nucleotide; Severity of Illness Index | 2022 |
Induction of bona fide regulatory T cells after liver transplantation - the potential influence of polyclonal antithymocyte globulin.
Topics: Adult; Animals; Antilymphocyte Serum; End Stage Liver Disease; Female; Flow Cytometry; Forkhead Transcription Factors; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphocyte Activation; Male; Methylation; Middle Aged; Rabbits; Real-Time Polymerase Chain Reaction; Retrospective Studies; T-Lymphocytes, Regulatory; Transplantation Conditioning | 2012 |